20 min listen
Clonal Hematopoiesis and Risk of T-MN, With Drs. Amy DeZern & Kelly Bolton
FromThe Hematologist
ratings:
Length:
16 minutes
Released:
Mar 1, 2021
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Amy DeZern has a conversation with Dr. Kelly Bolton. They discuss Dr. DeZern’s Diffusion article from the March/April 2021 issue of The Hematologist, titled, "Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors." They discuss the relationship between clonal hematopoiesis and the risk of therapy-related myeloid neoplasms which can help tailor individualized therapy. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/475183/Short-term-Gain-But-Long-term-Pain-Clonal.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Mar 1, 2021
Format:
Podcast episode
Titles in the series (100)
The Unfiltered Truth: Anticoagulation Alone is Highly Effective, even in Patients with High-risk PE: In his recent Diffusion article from the July/August issue of The Hematologist, Dr. David Garcia (University of Washington School of Medicine, University of Washington Medical Center, Seattle, WA) discusses the PREPIC2 study. The PREPIC2 results, publishe by The Hematologist